Evidence map›Paper›PMID 23047559›Full record

ArticleBioinformatics (Oxford, England)2013

Promoter-proximal CCCTC-factor binding is associated with an increase in the transcriptional pausing index.

Sur Herrera Paredes, Michael F Melgar, Praveen Sethupathy

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Enhancer-gene specificity in development and disease.Development (Cambridge, England) · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. CTCF and cellular heterogeneity.Cell & bioscience · 2019
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. CTCF: making the right connections.Genes & development · 2016
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sur Herrera ParedesCurriculum in Bioinformatics and Computational Biology, Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Michael F Melgar
Praveen Sethupathy

Funding

Discovery of microRNA regulatory modules controlling human pancreatic islet functR00DK091318 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SETHUPATHY, PRAVEEN · 2012 to 2014
$737k
NIDDK NIH HHS K99 DK091318NIDDK NIH HHS R00 DK091318NIDDK NIH HHS R00 DK091318-02
6 · The paper itself

Abstract

motivationIt has been known for more than 2 decades that after RNA polymerase II (RNAPII) initiates transcription, it can enter into a paused or stalled state immediately downstream of the transcription start site before productive elongation. Recent advances in high-throughput genomic technologies facilitated the discovery that RNAPII pausing at promoters is a widespread physiologically regulated phenomenon. The molecular underpinnings of pausing are incompletely understood. The CCCTC-factor (CTCF) is a ubiquitous nuclear factor that has diverse regulatory functions, including a recently discovered role in promoting RNAPII pausing at splice sites.

resultsIn this study, we analyzed CTCF binding sites and nascent transcriptomic data from three different cell types, and found that promoter-proximal CTCF binding is significantly associated with RNAPII pausing.

Indexed as

Promoter Regions, GeneticTranscription, GeneticAnimalsBinding SitesCCCTC-Binding FactorCell LineCells, CulturedHumansMiceRepressor ProteinsRNA Polymerase IICCCTC-Binding FactorCTCF protein, humanCtcf protein, mouseRepressor ProteinsRNA Polymerase II

Identifiers

PMID23047559
PMCPMC3673211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.